General Characteristics and Cytotoxic Effects of Nano-Poly (Butyl Cyanoacrylate) Containing Carboplatin on Ovarian Cancer Cells

Document Type : Research Articles

Authors

1 Department of Toxicology, Faculty of Pharmacy, Islamic Azad University, Shahreza Branch, Shahreza, Iran

2 Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, Iran

3 Department of Agronomy and Plant Breeding, College of Agriculture, University of Zanjan, Zanjan, Iran

4 Department of Toxicology and Pharmacology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran

5 Department of microbiology, parasitology and immunology, faculty of medicine, rafsanjan university of medical sciences, rafsanjan, Iran

6 Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran

Abstract

 
The initial response to treatment and subsequent development of resistance to carboplatin are very important challenges. Use of nano drug delivery is a new method to replace standard chemotherapy. In this research, both non-PEGylated and PEGylated nanoparticles (NPs) were prepared by mini-emulsion polymerization of poly (butyl cyanoacrylate) (PBCA) NPs. Characteristics such as size, polydispersity index (PDI), zeta potential, drug release, and stability were examined. In addition, infrared spectroscopy was used for description of the produced NPs. Then, cytotoxicity effects of both formulations were studied on the A2780CIS ovarian cancer cell line with incubation for 24, 48, and 72h. Examination of characteristics of loaded carboplatin on the PBCA NPs under suitable laboratory conditions showed a positive effect of PEG on their properties. Cytotoxicity studies demonstrated greater toxicity with both formulations of nano-drugs than the free drug. The results indicated that PBCA NPs can be considered as suitable candidates for nano-drugs in chemotherapy.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 18, Issue 1
January 2017
Pages 87-91

Files

History

  • Receive Date: 22 September 2016
  • Revise Date: 08 January 2017
  • Accept Date: 10 February 2017

Share

How to cite

Statistics